Rockefeller Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-330
| Closed | -$9K | – | 4021 |
|
|
2022
Q4 | $9K | Buy |
330
+285
| +633% | +$7.77K | ﹤0.01% | 3149 |
|
|
2022
Q3 | $1K | Sell |
45
-107
| -70% | -$2.38K | ﹤0.01% | 3807 |
|
|
2022
Q2 | $6K | Buy |
+152
| New | +$6K | ﹤0.01% | 3401 |
|
|
2021
Q1 | – | Sell |
-19
| Closed | – | – | 3420 |
|
|
2020
Q4 | $0 | Buy |
+19
| New | – | ﹤0.01% | 3038 |
|
|
2020
Q3 | – | Sell |
-16
| Closed | -$1K | – | 2848 |
|
|
2020
Q2 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 2530 |
|